{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:56:01Z","timestamp":1787601361485,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-025-06154-z","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:42:56Z","timestamp":1756374176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Three-year experience with GLP-2 analog in intestinal rehabilitation for pediatric-onset short bowel syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"Yuko","family":"Tazuke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Uga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Oue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"6154_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jpn3.12276","volume":"79","author":"PW Wales","year":"2024","unstructured":"Wales PW, Hill S, Robinson I (2024) Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure. J Pediatr Gastroenterol Nutr 79:290\u2013300. https:\/\/doi.org\/10.1002\/jpn3.12276","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6154_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.5223\/pghn.2019.22.4.303","volume":"22","author":"O Goulet","year":"2019","unstructured":"Goulet O, Abi Nader E, Pigneur B, Lambe C (2019) Short bowel syndrome as the leading cause of intestinal failure in early life: some insights into the management. Pediatr Gastroenterol Hepatol Nutr 22:303\u2013329. https:\/\/doi.org\/10.5223\/pghn.2019.22.4.303","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"6154_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.sempedsurg.2017.09.006","volume":"26","author":"BS Fullerton","year":"2017","unstructured":"Fullerton BS, Hong CR, Jaksic T (2017) Long-term outcomes of pediatric intestinal failure. Semin Pediatr Surg 26:328\u2013335. https:\/\/doi.org\/10.1053\/j.sempedsurg.2017.09.006","journal-title":"Semin Pediatr Surg"},{"key":"6154_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MPG.0000000000000735","volume":"61","author":"Y Avitzur","year":"2015","unstructured":"Avitzur Y, Wang JY, de Silva NT, Burghardt KM et al (2015) Impact of intestinal rehabilitation program and its innovative therapies on the outcome of intestinal transplant candidates. J Pediatr Gastroenterol Nutr 61:18\u201323. https:\/\/doi.org\/10.1097\/MPG.0000000000000735","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6154_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","volume":"76","author":"DJ Drucker","year":"2014","unstructured":"Drucker DJ, Yusta B (2014) Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol 76:561\u2013583. https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170317","journal-title":"Annu Rev Physiol"},{"key":"6154_CR6","doi-asserted-by":"publisher","first-page":"E134","DOI":"10.1152\/ajpendo.2000.278.1.E134","volume":"278","author":"W Tavares","year":"2000","unstructured":"Tavares W, Drucker DJ, Brubaker PL (2000) Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. Am J Physiol Endocrinol Metab 278:E134\u2013E139. https:\/\/doi.org\/10.1152\/ajpendo.2000.278.1.E134","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6154_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nbt0797-673","volume":"15","author":"DJ Drucker","year":"1997","unstructured":"Drucker DJ, Shi Q, Crivici A et al (1997) Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 15:673\u2013677. https:\/\/doi.org\/10.1038\/nbt0797-673","journal-title":"Nat Biotechnol"},{"key":"6154_CR8","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","volume":"143","author":"PB Jeppesen","year":"2012","unstructured":"Jeppesen PB, Pertkiewicz M, Messing B et al (2012) Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 143:1473\u20131481. https:\/\/doi.org\/10.1053\/j.gastro.2012.09.007","journal-title":"Gastroenterology"},{"key":"6154_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","volume":"181","author":"BA Carter","year":"2017","unstructured":"Carter BA, Cohran VC, Cole CR et al (2017) Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr 181:102\u2013111. https:\/\/doi.org\/10.1016\/j.jpeds.2016.10.027","journal-title":"J Pediatr"},{"key":"6154_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/jpen.1690","volume":"44","author":"SA Kocoshis","year":"2020","unstructured":"Kocoshis SA, Merritt RJ, Hill S et al (2020) Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase III study. J Parenter Enteral Nutr 44:621\u2013631. https:\/\/doi.org\/10.1002\/jpen.1690","journal-title":"J Parenter Enteral Nutr"},{"key":"6154_CR11","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/jpen.2061","volume":"45","author":"S Hill","year":"2021","unstructured":"Hill S, Carter BA, Cohran V et al (2021) Safety findings in pediatric patients during long-term treatment with teduglutide for short-bowel syndrome-associated intestinal failure: pooled analysis of 4 clinical studies. J Parent Ent Nutr 45:1456\u20131465. https:\/\/doi.org\/10.1002\/jpen.2061","journal-title":"J Parent Ent Nutr"},{"key":"6154_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jpen.1588","volume":"44","author":"K Chen","year":"2020","unstructured":"Chen K, Mu F, Xie J, Kelkar SS et al (2020) Impact of teduglutide on quality of life in patients with short bowel syndrome and intestinal failure. JPEN J Parenter Enteral Nutr 44:119\u2013128. https:\/\/doi.org\/10.1002\/jpen.1588","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6154_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","volume":"32","author":"PB Jeppesen","year":"2013","unstructured":"Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L et al (2013) Quality of life in patients with short bowel syndrome treated with teduglutide, a new glucagon-like peptide-2 analogue: results of a randomised placebo-controlled trial. Clin Nutr 32:713\u2013721. https:\/\/doi.org\/10.1016\/j.clnu.2013.03.016","journal-title":"Clin Nutr"},{"key":"6154_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","volume":"35","author":"L Pironi","year":"2016","unstructured":"Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB et al (2016) ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 35:247\u2013307. https:\/\/doi.org\/10.1016\/j.clnu.2016.01.020","journal-title":"Clin Nutr"},{"key":"6154_CR15","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1177\/014860719902300527","volume":"23","author":"M Wasa","year":"1999","unstructured":"Wasa M, Takagi Y, Sando K, Harada T, Okada A (1999) Long-term outcome of short bowel syndrome in adult and pediatric patients. J Parenter Enteral Nutr 23:S110\u2013S112. https:\/\/doi.org\/10.1177\/014860719902300527","journal-title":"J Parenter Enteral Nutr"},{"key":"6154_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/MPG.0000000000002899","volume":"146","author":"JM Rhoads","year":"2005","unstructured":"Rhoads JM, Plunkett E, Galanko J et al (2005) Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 146:542\u2013547. https:\/\/doi.org\/10.1097\/MPG.0000000000002899","journal-title":"J Pediatr"},{"key":"6154_CR17","doi-asserted-by":"publisher","first-page":"175628481879334","DOI":"10.1177\/1756284818793343","volume":"11","author":"M Schoeler","year":"2018","unstructured":"Schoeler M, Klag T, Wendler BS et al (2018) GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting. Therap Adv Gastroenterol 11:1756284818793343. https:\/\/doi.org\/10.1177\/1756284818793343","journal-title":"Therap Adv Gastroenterol"},{"key":"6154_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MPG.0000000000002899","volume":"71","author":"ER Boluda","year":"2020","unstructured":"Boluda ER, Ferreiro SR, Moral OM et al (2020) Experience with teduglutide in pediatric short bowel syndrome: first real-life data. J Pediatr Gastroenterol Nutr 71:734\u2013739. https:\/\/doi.org\/10.1097\/MPG.0000000000002899","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6154_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1177\/0148607114527772","volume":"38","author":"PW Wales","year":"2014","unstructured":"Wales PW, Allen NA, Worthington P et al (2014) ASPEN Clinical guidelines: support of pediatric patients with intestinal failure at risk of PN-associated liver disease. JPEN J Parenter Enteral Nutr 38:538\u2013557. https:\/\/doi.org\/10.1177\/0148607114527772","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"6154_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1053\/j.gastro.2024.11.023","volume":"168","author":"PB Jeppesen","year":"2025","unstructured":"Jeppesen PB, Vanuytsel T, Subramanian S, Joly F, Wanten G, Lamprecht G et al (2025) Glepaglutide, a long-acting glucagon-like peptide-2 analogue, reduces parenteral support in patients with short bowel syndrome: a phase 3 randomized controlled trial. Gastroenterology 168:701\u2013713. https:\/\/doi.org\/10.1053\/j.gastro.2024.11.023","journal-title":"Gastroenterology"},{"key":"6154_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.clnesp.2024.10.161","volume":"64","author":"T Vanuytsel","year":"2024","unstructured":"Vanuytsel T, Lakananurak N, Greif S et al (2024) Real-world experience with glucagon-like peptide 2 analogues in patients with short bowel syndrome and chronic intestinal failure: results from an international survey in expert intestinal failure centers. Clin Nutr ESPEN 64:496\u2013502. https:\/\/doi.org\/10.1016\/j.clnesp.2024.10.161","journal-title":"Clin Nutr ESPEN"},{"key":"6154_CR22","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","volume":"39","author":"DF Joly","year":"2020","unstructured":"Joly DF, Nuzzo SA, Chambrier C, Beau P, Poullenot F et al (2020) Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study. Clin Nutr 39:2856\u20132862. https:\/\/doi.org\/10.1016\/j.clnu.2019.12.019","journal-title":"Clin Nutr"},{"key":"6154_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/jpen.1838","volume":"45","author":"F Puello","year":"2021","unstructured":"Puello F, Wall E, Herlitz J, Lozano ES, Semrad C et al (2021) Long-term outcomes with teduglutide from a single center. JPEN - J Parenter Enter Nutr 45:318\u2013322. https:\/\/doi.org\/10.1002\/jpen.1838","journal-title":"JPEN - J Parenter Enter Nutr"},{"key":"6154_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113882","volume":"272","author":"U Cucinotta","year":"2024","unstructured":"Cucinotta U, Acunzo M, Payen E et al (2024) Impact of teduglutide on real-life healthcare costs in children with short bowel syndrome. J Pediatr 272:113882. https:\/\/doi.org\/10.1016\/j.jpeds.2023.113882","journal-title":"J Pediatr"},{"key":"6154_CR25","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.clnu.2019.08.020","volume":"39","author":"AD Armstrong","year":"2020","unstructured":"Armstrong AD, Forbes PB, Jepsen HM, Lee NP, Sidner DL (2020) Colonic polyps before and after treatment with teduglutide in patients with short bowel syndrome: a post-hoc analysis of the STEPS study series. Clin Nutr 39:1774\u20131777. https:\/\/doi.org\/10.1016\/j.clnu.2019.08.020","journal-title":"Clin Nutr"},{"key":"6154_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ajcnut.2023.02.015","volume":"117","author":"B de Dreuille","year":"2023","unstructured":"de Dreuille B, Cazals-Hatem D, Ronot M et al (2023) Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring. Am J Clin Nutr 117:1143\u20131151. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.02.015","journal-title":"Am J Clin Nutr"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-025-06154-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:27:47Z","timestamp":1763630867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-025-06154-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6154"],"URL":"https:\/\/doi.org\/10.1007\/s00383-025-06154-z","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Osaka University Hospital (approval No. 20354\u20133). Written informed consent was waived owing to the retrospective and non-interventional design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}],"article-number":"273"}}